CymitQuimica logo

CAS 1127442-87-8

:

Formula:C25H19N3O3
InChI:InChI=1S/C25H19N3O3/c29-23(27-19-5-1-3-14-4-2-12-26-22(14)19)15-8-10-18(11-9-15)28-24(30)20-16-6-7-17(13-16)21(20)25(28)31/h1-12,16-17,20-21H,13H2,(H,27,29)/t16-,17+,20+,21-
InChI key:ZGSXEXBYLJIOGF-BTYSMDAFSA-N
SMILES:C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2C(=O)N(C3=O)C4=CC=C(C=C4)C(=O)NC5=CC=CC6=C5N=CC=C6
Found 5 products.
  • exo-IWR-1

    CAS:
    exo-IWR-1
    Formula:C25H19N3O3
    Purity:97%
    Molecular weight:409.44

    Ref: 54-BUP10505

    25mg
    72.00€
    50mg
    118.00€
    100mg
    186.00€
  • Ref: IN-DA008SRY

    5mg
    122.00€
    10mg
    192.00€
    25mg
    343.00€
    50mg
    656.00€
    100mg
    797.00€
  • exo-IWR-1

    CAS:
    exo-IWR-1 (exo-IWR 1) is an inactive stereoisomer of Endo-IWR-1,and is a negative control of IWR-1. IWR-1 is a tankyrase inhibitor which inhibits Wnt/β-catenin
    Formula:C25H19N3O3
    Purity:97.41%
    Color and Shape:Solid
    Molecular weight:409.44

    Ref: TM-T22775

    1mL*10mM (DMSO)
    33.00€
    25mg
    50.00€
    50mg
    79.00€
    100mg
    114.00€
  • exo-IWR-1

    Controlled Product
    CAS:

    Applications exo-IWR-1 is the enantiomer of IWR-1 (I941800). exo-IWR-1 is an SAR anticancer Wnt response inhibitor. Such compounds may be used in the treatment of Wnt protein signaling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.
    References Lepourcelet, M., et al.: Cancer Cell, 5, 91 (2004), Barker, N., et al.: Nat. Rev. Drug Disc., 5, 997 (2006), Clevers, H., et al.: Cell, 127, 469 (2006), Jin, G., et al.: Bioorg. Med. Chem. Lett., 19, 606 (2009),

    Formula:C25H19N3O3
    Color and Shape:Neat
    Molecular weight:409.437

    Ref: TR-I941805

    100mg
    1,417.00€
  • exo-IWR-1

    CAS:
    Negative control for endo-IWR-1
    Formula:C25H19N3O3
    Purity:Min. 95%
    Molecular weight:409.44 g/mol

    Ref: 3D-FE23213

    10mg
    310.00€
    50mg
    691.00€